Concepedia

Dominik Lott

DL

Statistics

Publications

5

Citations

125

H-Index

5

Active since

2016

Affiliations

Actelion (Switzerland)(Current)

Saarland University

Dominik Lott is an author at Actelion (Switzerland) specializing in immunology, autoimmunity, and immune regulation.

ORCID

Top concepts

Publications per year

2016–2022

5

Publications

5

Biomarker‐guided clinical development of the first‐in‐class anti‐inflammatory FPR2/ALX agonist ACT‐389949

Anna K. Stalder, Dominik Lott, Daniel S. Strasser et al. · British Journal of Clinical Pharmacology · 2016 · 70 citations · Full text

In silico exploration of amyloid‐related imaging abnormalities in the gantenerumab open‐label extension trials using a semi‐mechanistic model

Roxana Aldea, Hans Peter Grimm, Ronald Gieschke et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2022 · 17 citations · Full text

Modeling Tolerance Development for the Effect on Heart Rate of the Selective S1P<sub>1</sub>Receptor Modulator Ponesimod

Dominik Lott, Thorsten Lehr, Jasper Dingemanse et al. · Clinical Pharmacology & Therapeutics · 2017 · 16 citations

Modeling the Effect of the Selective S1P1 Receptor Modulator Ponesimod on Subsets of Blood Lymphocytes

Dominik Lott, Andreas Krause, Christian A. Seemayer et al. · Pharmaceutical Research · 2016 · 11 citations

, , +10

Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial Hypertension

Andreas Krause, Matthias Macháček, Dominik Lott et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 11 citations · Full text

1–5 of 5